Abstract:Copper (Cu), an essential micronutrient with redox properties, plays a pivotal role in a wide array of pathological and physiological processes across virtually all cell types. Maintaining an optimal copper concentration is critical for cellular survival: insufficient copper levels disrupt respiration and metabolism, while excess copper compromises cell viability, potentially leading to cell death. Similarly, in the context of cancer, copper exhibits a dual role: appropriate amount of copper can promote tumor progression and be an accomplice, yet beyond befitting level, copper can bring about multiple types of cell death, including autophagy, apoptosis, ferroptosis, immunogenic cell death, pyroptosis, and cuproptosis. These forms of cell death are beneficial against cancer progression; however, achieving precise copper regulation within tumors remains a significant challenge in the pursuit of effective cancer therapies. The emergence of nanodrug delivery systems, distinguished by their precise targeting, controlled release, high payload capacity, and the ability to co-deliver multiple agents, has revitalized interest in exploiting copper's precise regulatory capabilities. Nevertheless, there remains a dearth of comprehensive review of copper's bidirectional effects on tumorigenesis and the role of copper-based nanomaterials in modulating tumor progression. This paper aims to address this gap by elucidating the complex role in cancer biology and highlighting its potential as a therapeutic target. Through an exploration of copper's dualistic nature and the application of nanotechnology, this review seeks to offer novel insights and guide future research in advancing cancer treatment.

Multifaceted Roles of Copper ions in Anticancer Nanomedicine

Copper As the Target for Anticancer Nanomedicine

Recent Advances in Cancer Therapeutic Copper-Based Nanomaterials for Antitumor Therapy

The Copper Age in Cancer Treatment: from Copper Metabolism to Cuproptosis

Cu-related Agents for Cancer Therapies

Harnessing nanomaterials for copper-induced cell death

Copper and Copper Complexes in Tumor Therapy

Biocompatible Copper-Based Nanocomposites for Combined Cancer Therapy

Dissecting copper biology and cancer treatment: ‘Activating Cuproptosis or suppressing Cuproplasia’

Recent Advances in Copper-Based Organic Complexes and Nanoparticles for Tumor Theranostics

Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies

Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment

Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes

Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies

Copper in cancer: from limiting nutrient to therapeutic target

Regenerating Chemotherapeutics through Copper-Based Nanomedicine: Disrupting Protein Homeostasis for Enhanced Tumor Therapy

Regulatory roles of copper metabolism and cuproptosis in human cancers

Targeting copper metabolism: a promising strategy for cancer treatment

Nanomedicine-based Disulfiram and Metal Ion Co-Delivery Strategies for Cancer Treatment

Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review

Copper in medicine: homeostasis, chelation therapy and antitumor drug design.